MS
DYN icon

Maven Securities’s Dyne Therapeutics DYN Stock Holding History

Maven Securities’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-36,596
Closed -$798K – 1102
2021
Q2 		$798K Sell
36,596
-54,966
-60% -$1.03M 0.03% 502
2021
Q1 		$1.39M Buy
+91,562
New +$1.77M 0.06% 297
2020
Q4 		– Sell
-10,600
Closed -$212K – 651
2020
Q3 		$212K Buy
+10,600
New +$233K 0.02% 547

Other funds holding DYN

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Maven Securities's DYN Position: Q3 2021 in Review

Maven Securities sold out of Dyne Therapeutics (DYN) in Q3 2021, closing a stake of 36,596 shares — an estimated $798K sold.

Maven Securities first reported a position in DYN in Q3 2020 and held it in 3 quarters. The position peaked at $1.39M in Q1 2021. 83 funds tracked by Wall St. Rank hold DYN as of Q3 2021.

  • Maven Securities reported no remaining Dyne Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Maven Securities sold 36,596 Dyne Therapeutics shares in Q3 2021, an estimated $798K.
  • Maven Securities first reported a position in Dyne Therapeutics in Q3 2020 and held it in 3 quarters.
  • Maven Securities's Dyne Therapeutics position peaked at $1.39M in Q1 2021.
  • 83 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2021.

Based on Maven Securities's 13F filing for Q3 2021, filed 15 Nov 2021.